Abstract
The conventional treatment currently applied in malignant brain tumors in adults consists of surgery, often followed by irradiation of the brain. The prognosis is not encouraging, as the survival median does not exceed 11 months [8, 17]. Studies by Frankel and German [5] showed that where surgery alone is used, the survival median is about 6 months after extensive exeresis and two, 5 months after partial exeresis. After simple biopsy, the spontaneous survival median is 10 months. Comparable results were reported in the retrospective work of Roth and Elwidge. Radiotherapy increases the survival median established after surgical treatment alone by about 4 months (Frankel and German [5]). Experimental results in animals [16], which were later confirmed in man [7, 10, 19, 20, 21, 23, 24, 4, 6], have shown the potential value of chemotherapy and led to the development of new therapeutic methods, despite the limited number of drugs available and the fact that their combined effect has not been studied [11].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ancri, D.: La cinégammagraphie cérébrale. Rev. Neurol. 125, 131–154 (1971).
Armentrout, S. A., Foltz, E., Vermund, H., Otis, P. T.: Comparison of post-operative irradiation alone and in combinations with BCNU (NSC 409.962) in the management of malignant gliomas. Cancer Chemoth., Rep. 58, 841–844 (1974).
Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, K. J.: Phase II study of l(2-chloroethyl.)3 cyclohexyl-1 nitrosourea (CCNU-NSC 79037) in treatment of brain tumours. Cancer Chemoth. Rep. 56, 421–427 (1972).
Fewer, D., Wilson, C. B., Boldrey, E. B., Enot, K. J., Powell, M. R.: The chemotherapy of brain tumours clinical experience with carmustine (BCNU) and vincristine. J.A.M.A. 222, 549–552 (1972).
Frankel, S. A., German, W. J.: Glioblastoma multiforme (review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment). J. Neuro Surg. 15, 489 (1958).
Goldsmith, M. A., Carter, S. K.: Glioblastoma multiforme, a review of therapy. Cancer Treat. Review 1, 153–165 (1974).
Hildebrand, J. H., Brihaye, J., Wagenknecht, L., Mitchel, J., Kenis, Y.: Combination chemotherapy with l(2-chloroethyl) 3 cyclohexyl-1 nitrosourea (CCNU), vincristine, and methotrexate in primary and metastasis brain tumours. A preliminary report. Europ. J. Cancer 9, 627–634 (1973).
Jelsma, R., Bucy, C.: Glioblastoma multiforme. Arch. Neurol. 20, 161–171 (1969).
Krayenbuhl, H. A., Yasargil, M. G.: Cerebral angiography. London: Butterworths and Co., 1968, pp. 272–273.
Lassman, L., Pearce, G. W., Gang, J.: Sensitivity of intracranial gliomata vincristine sulfate. Lancet (1965) I, 296–297.
Levin, V. A., Wilson, Ch.B.: Chemotherapy: the agents in current use. Sem. in Oncology 2, 63–67 (1975).
Pouillart, P., Hoang Thy Huong, T., Brugerie, E., Lheritier, J.: Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiations. Biomedicine 21, 471–479 (1974).
Pouillart, P., Schwarzanberg, L., Amiel, J. L., Mathe, G., Huguenin, P., Morin, P., Baron, A., Laparre Ch., Parrot, R.: Combinaisons chimiothérapiques de drogues se potentialisant. III. Application aux tumeurs du système nerveux central. Nouv. Press Med. 4, 721–724 (1975).
Pratt, C. B., Shanks, E. C.: Hyperpigmentation of nails from doxorubicin. J.A.M.A. 228, 460 (1974).
Rosenblum, M. L., Reynolds, A. F., Smith, K. A., Rumack, B. H., Walcker: Chloroethyl-cyclo-hexyl-nitrosourea (CCNU) in the treatment of malignant brain tumours. J. Neurol. Surg. 39, 306–324 (1973).
Schabel, F. M., Jr., Johnston, F. P., Caleb, G. S.: Experimental evaluation of potential anticancer agents. VIII. Effects of certain nitrosoureas on intra cerebral L1210 leukaemias. Cancer Research 23, 725–733 (1963).
Shapiro, W. R., Posner, J. B.: The chemotherapy of brain tumours. A clinical and experimental review. In: Recent Advances in Neurology. Plum, F. (ed.)., 1969, pp. 149–235.
Sklansky, B. D., Mann-Kaplan, R. S., Reynolds, A. F., Rosenblum, M. L., Walker, M. D.: 4’ Demethyl-epipodophylotoxin. D. Thenylidene glucoside (PT6) in the treatment of malignant intracranial neoplasms. Cancer 33, 460–467 (1974).
Triarte, P. V., Hananian, J., Cortner, J. A.: Central nervous system leukaemia with 1–3 bis (2 chloroethyl)-1 nitrosourea (BCNU). Cancer 19, 1187–1194 (1966).
Walker, M. D., Hurwitz, B. S.: BCNU (1,3 bis (2-chloroethyl)-1 nitrosourea: NSC—409.962) in the treatment of malignant brain tumours. Cancer Chemoth. Rep. 4, 263–273 (1970).
Walker, M. D., Geham, E. A.: An evaluation of 1,3 bis (2 chloroethyl)-l nitrosourea (BCNU) and irradiation alone and in combination for the treatment of malignant glioma. Ann. Meet. Am. Ass. Cancer Res. 13 (Abstract No. 63) (1972).
Walker, M. D.: Chemotherapy: adjuvant to surgery and radiation therapy. Seminars in Oncology 2, 69–72 (1975).
Wilson, C. B., Boldrey, E. B., Enot, K. J.: 1,3 bis (2 chloroethyl)-l nitrosourea (NSC 409962) in the treatment of malignant brain tumours. Cancer Chemoth. Rep. 54, 273–281 (1970).
Wilson, C. B., Hoshino, T.: Current trials in the chemotherapy brain tumours with special references to glioblastoma. J. Neurol. Surg. 31, 589–603 (1969).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Pouillart, P. et al. (1977). Treatment of Malignant Gliomas and Brain Metastases in Adults Using a Combination of Adriamycine, VM 26, and CCNU Results of a Type II Trial. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-81174-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81176-0
Online ISBN: 978-3-642-81174-6
eBook Packages: Springer Book Archive